Podcast Episodes
Back to SearchManaging ADHD in Pregnancy: Weighing Risk versus Risk
In this episode, we explore the nuanced challenge of managing ADHD with stimulant medications during pregnancy. Is stopping the medication always the…
4 months, 4 weeks ago
Ondansetron for Negative Symptoms of Schizophrenia
In this episode, we examine a surprising repurposing of ondansetron — a common antiemetic — as a potential adjunctive treatment for the notoriously h…
5 months ago
Managing SSRIs During Pregnancy: Myths vs. Evidence
In this episode, we explore how to manage SSRI treatment in pregnant patients — addressing common fears around fetal malformations, medication switch…
5 months, 1 week ago
Rethinking Haloperidol's Cardiac Risk
In this episode, we explore a landmark meta-analysis that challenges decades of fear surrounding IV haloperidol and cardiac risk. Could one of medici…
5 months, 1 week ago
Bipolar Disorder, Lithium, and Pregnancy: What the Evidence Says
In this episode, we explore the complex risk-versus-risk decision of using lithium during pregnancy and breastfeeding. How do you weigh the near-cert…
5 months, 2 weeks ago
Clozapine Monitoring: New Guidelines for the Post-REMS Era
In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable cloz…
5 months, 3 weeks ago
Prescribing Through Pregnancy: Dosing, Levels, and Relapse Risk
In this episode, we explore how pregnancy reshapes the pharmacokinetics of psychiatric medications — and what that means for your patients. Can stopp…
5 months, 4 weeks ago
Bright Light Therapy for Bipolar Depression
In this episode, we explore bright light therapy (BLT) as a powerful adjunctive treatment for bipolar depression — examining the neuroscience behind …
6 months ago
Lithium: Managing Cosmetic and Sexual Side Effects
In this episode, we explore three often-overlooked side effects of lithium — sexual dysfunction, hair loss, and skin changes like acne and psoriasis …
6 months, 1 week ago
KarXT: A New Era in Antipsychotics?
In this episode, we explore KarXT, a newly FDA-approved antipsychotic with a groundbreaking cholinergic mechanism, through the lens of a single power…
6 months, 1 week ago